Jon Congleton's Net Worth
Jon Congleton's net worth is estimated to be at least $2,045,529.86 as of 05/14/2026. CoreStreet's estimation of Jon Congleton's net worth is based on their sale of stock and current holding of stock.
Jon Congleton is CEO at Mineralys Therapeutics Inc. Common Stock. They have executed at least 16 trades of stock as per SEC Form 4 filings. Their most recent trade was for 15,730 units of MLYS stock on 04/13/2026. Their biggest sale was on 04/13/2026 when they sold 15,730 units of Mineralys Therapeutics Inc. Common Stock stock for $422,035.90. They typically trade 2 times per year.
Total value of insider buys:
- $208,407.50
Total value of insider sells:
- $1,837,122.36
Most recent insider trade:
- April 13, 2026
Jon Congleton's Insider Trading History
| Mineralys Therapeutics Inc. Common Stock | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 13, 2026 | CEO | 15,730 | $26.83 | Sell | $422,035.90 |
July 11, 2025 | CEO | 15,884 | $14.51 | Sell | $230,476.84 |
April 11, 2025 | CEO | 15,319 | $12.19 | Sell | $186,738.61 |
Jan. 13, 2025 | CEO | 18,333 | $9.06 | Sell | $166,096.98 |
Oct. 11, 2024 | CEO | 15,271 | $13.52 | Sell | $206,463.92 |
July 11, 2024 | CEO | 15,746 | $13.34 | Sell | $210,051.64 |
June 14, 2024 | CEO | 16,229 | $12.52 | Sell | $203,187.08 |
June 12, 2024 | CEO | 16,607 | $12.77 | Sell | $212,071.39 |
Nov. 22, 2023 | CEO | 4,250 | $5.97 | Buy | $25,372.50 |
Sept. 6, 2023 | CEO | 2,250 | $12.08 | Buy | $27,180.00 |
Aug. 17, 2023 | CEO | 2,250 | $12.10 | Buy | $27,225.00 |
Aug. 11, 2023 | CEO | 2,000 | $12.89 | Buy | $25,780.00 |
| Alpine Immune Sciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 16, 2016 | CEO | 5,000 | $3.87 | Buy | $19,350.00 |
March 24, 2016 | CEO | 5,000 | $4.22 | Buy | $21,100.00 |
March 22, 2016 | CEO | 5,000 | $4.38 | Buy | $21,900.00 |
Dec. 11, 2015 | CEO | 5,000 | $8.10 | Buy | $40,500.00 |